Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Transplantation | 64 | 2024 | 1310 | 9.830 |
Why?
|
HLA Antigens | 10 | 2024 | 1338 | 2.940 |
Why?
|
Isoantibodies | 6 | 2021 | 682 | 1.910 |
Why?
|
Lymphangioleiomyomatosis | 12 | 2023 | 208 | 1.810 |
Why?
|
Bronchiolitis Obliterans | 6 | 2024 | 220 | 1.690 |
Why?
|
Lung Diseases, Interstitial | 12 | 2023 | 935 | 1.610 |
Why?
|
Idiopathic Pulmonary Fibrosis | 12 | 2023 | 520 | 1.510 |
Why?
|
Tissue Donors | 11 | 2024 | 2377 | 1.480 |
Why?
|
Primary Graft Dysfunction | 5 | 2021 | 112 | 1.440 |
Why?
|
Connective Tissue Diseases | 3 | 2024 | 285 | 1.340 |
Why?
|
Histocompatibility Testing | 7 | 2024 | 716 | 1.230 |
Why?
|
Gastroesophageal Reflux | 12 | 2024 | 833 | 1.200 |
Why?
|
Lung Diseases | 8 | 2024 | 1926 | 1.190 |
Why?
|
Graft Rejection | 17 | 2024 | 4505 | 1.070 |
Why?
|
Pulmonary Fibrosis | 5 | 2023 | 507 | 0.870 |
Why?
|
Photopheresis | 2 | 2021 | 36 | 0.730 |
Why?
|
Histocompatibility | 2 | 2018 | 322 | 0.670 |
Why?
|
Vascular Endothelial Growth Factor D | 3 | 2017 | 63 | 0.640 |
Why?
|
Drug Labeling | 1 | 2021 | 250 | 0.640 |
Why?
|
Esophageal pH Monitoring | 11 | 2024 | 203 | 0.620 |
Why?
|
Carbon Monoxide | 3 | 2019 | 551 | 0.590 |
Why?
|
Sirolimus | 7 | 2019 | 1542 | 0.560 |
Why?
|
Heart Transplantation | 4 | 2023 | 3291 | 0.540 |
Why?
|
Survival Rate | 10 | 2024 | 12875 | 0.500 |
Why?
|
Preoperative Period | 3 | 2016 | 564 | 0.480 |
Why?
|
Sarcoma, Kaposi | 1 | 2018 | 374 | 0.480 |
Why?
|
Tissue and Organ Procurement | 2 | 2020 | 983 | 0.460 |
Why?
|
Hospitalization | 4 | 2019 | 10845 | 0.450 |
Why?
|
Postoperative Complications | 8 | 2024 | 15880 | 0.430 |
Why?
|
Immunomodulation | 1 | 2017 | 550 | 0.420 |
Why?
|
Esophagitis, Peptic | 2 | 2023 | 77 | 0.410 |
Why?
|
Respiratory Tract Infections | 3 | 2017 | 1013 | 0.390 |
Why?
|
Transplantation | 1 | 2013 | 221 | 0.380 |
Why?
|
Inhalation Exposure | 1 | 2013 | 433 | 0.360 |
Why?
|
Lung Neoplasms | 8 | 2023 | 13589 | 0.360 |
Why?
|
Burkholderia Infections | 2 | 2022 | 41 | 0.350 |
Why?
|
Retrospective Studies | 41 | 2024 | 81834 | 0.350 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1884 | 0.350 |
Why?
|
Delirium | 1 | 2022 | 1694 | 0.340 |
Why?
|
Antibodies | 1 | 2017 | 2425 | 0.330 |
Why?
|
Middle Aged | 63 | 2024 | 223418 | 0.330 |
Why?
|
Antibiotics, Antineoplastic | 3 | 2019 | 679 | 0.330 |
Why?
|
Graft Survival | 5 | 2024 | 3890 | 0.330 |
Why?
|
Immunosuppressive Agents | 7 | 2023 | 4213 | 0.320 |
Why?
|
Humans | 107 | 2024 | 768451 | 0.320 |
Why?
|
Lung | 14 | 2023 | 10090 | 0.300 |
Why?
|
Time Factors | 12 | 2023 | 40271 | 0.300 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 2 | 2018 | 119 | 0.270 |
Why?
|
Male | 64 | 2024 | 364781 | 0.270 |
Why?
|
Aged | 39 | 2024 | 171520 | 0.260 |
Why?
|
Female | 70 | 2024 | 396943 | 0.260 |
Why?
|
Organ Transplantation | 3 | 2022 | 1177 | 0.250 |
Why?
|
Length of Stay | 2 | 2020 | 6521 | 0.250 |
Why?
|
Burkholderia cepacia complex | 2 | 2022 | 24 | 0.240 |
Why?
|
Esophageal Motility Disorders | 2 | 2023 | 49 | 0.240 |
Why?
|
Patient Readmission | 2 | 2016 | 3308 | 0.240 |
Why?
|
Patient Discharge | 1 | 2018 | 3471 | 0.240 |
Why?
|
Treatment Outcome | 19 | 2024 | 65409 | 0.240 |
Why?
|
Cystic Fibrosis | 3 | 2018 | 1287 | 0.240 |
Why?
|
Immunologic Factors | 1 | 2014 | 1600 | 0.240 |
Why?
|
Rectal Diseases | 1 | 2005 | 142 | 0.230 |
Why?
|
Hospital Mortality | 1 | 2018 | 5371 | 0.230 |
Why?
|
Hyaluronic Acid | 2 | 2019 | 489 | 0.220 |
Why?
|
Colonic Diseases | 1 | 2005 | 203 | 0.220 |
Why?
|
Proportional Hazards Models | 6 | 2024 | 12561 | 0.220 |
Why?
|
Electric Impedance | 8 | 2023 | 796 | 0.220 |
Why?
|
Antiviral Agents | 3 | 2019 | 3063 | 0.220 |
Why?
|
Hydroxychloroquine | 2 | 2018 | 427 | 0.220 |
Why?
|
Adult | 43 | 2024 | 223542 | 0.210 |
Why?
|
Burkholderia cepacia | 1 | 2022 | 22 | 0.210 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39430 | 0.210 |
Why?
|
Prognosis | 10 | 2024 | 30028 | 0.200 |
Why?
|
Pseudomonas | 1 | 2022 | 124 | 0.200 |
Why?
|
Vital Capacity | 5 | 2017 | 984 | 0.200 |
Why?
|
Interferon Type I | 1 | 2006 | 566 | 0.200 |
Why?
|
Telomere | 3 | 2021 | 943 | 0.200 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 2022 | 1482 | 0.190 |
Why?
|
Enoxaparin | 1 | 2023 | 391 | 0.180 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2017 | 2067 | 0.180 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5367 | 0.180 |
Why?
|
Anxiety | 1 | 2015 | 4655 | 0.180 |
Why?
|
Hydrogen-Ion Concentration | 7 | 2023 | 2488 | 0.180 |
Why?
|
Sarcoidosis | 1 | 2006 | 539 | 0.180 |
Why?
|
Resource Allocation | 1 | 2023 | 353 | 0.180 |
Why?
|
Air Pollution | 1 | 2013 | 2364 | 0.170 |
Why?
|
Arthritis, Psoriatic | 1 | 2022 | 220 | 0.170 |
Why?
|
Air Pollutants | 1 | 2013 | 2905 | 0.170 |
Why?
|
Health Care Rationing | 1 | 2023 | 436 | 0.170 |
Why?
|
Psychomotor Agitation | 1 | 2022 | 307 | 0.160 |
Why?
|
Fibrosis | 3 | 2023 | 2076 | 0.160 |
Why?
|
Incidence | 8 | 2023 | 21552 | 0.160 |
Why?
|
Polyamines | 1 | 2019 | 133 | 0.160 |
Why?
|
Endostatins | 1 | 2019 | 168 | 0.160 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2018 | 72 | 0.150 |
Why?
|
Hermanski-Pudlak Syndrome | 1 | 2018 | 20 | 0.150 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2020 | 321 | 0.150 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2024 | 1362 | 0.150 |
Why?
|
Carbamates | 1 | 2019 | 192 | 0.140 |
Why?
|
Quality of Life | 2 | 2018 | 13497 | 0.140 |
Why?
|
Respiratory Function Tests | 4 | 2020 | 1697 | 0.140 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 1051 | 0.140 |
Why?
|
Steroids | 1 | 2022 | 937 | 0.140 |
Why?
|
Chronic Disease | 4 | 2024 | 9382 | 0.140 |
Why?
|
Forced Expiratory Volume | 6 | 2019 | 1820 | 0.130 |
Why?
|
Vesicular Transport Proteins | 1 | 2019 | 377 | 0.130 |
Why?
|
Personal Autonomy | 1 | 2019 | 315 | 0.130 |
Why?
|
Catheters, Indwelling | 1 | 2019 | 436 | 0.130 |
Why?
|
Adjustment Disorders | 1 | 2016 | 68 | 0.130 |
Why?
|
Glomerular Mesangium | 2 | 2001 | 98 | 0.130 |
Why?
|
Risk Factors | 11 | 2024 | 74915 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 757 | 0.130 |
Why?
|
Depression | 1 | 2015 | 8235 | 0.130 |
Why?
|
Embolism, Fat | 1 | 2015 | 46 | 0.130 |
Why?
|
Autoantibodies | 1 | 2024 | 2131 | 0.130 |
Why?
|
Arthritis, Rheumatoid | 2 | 2022 | 3763 | 0.130 |
Why?
|
Patient Selection | 3 | 2021 | 4266 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2015 | 127 | 0.120 |
Why?
|
Proton Pump Inhibitors | 2 | 2017 | 552 | 0.120 |
Why?
|
Carcinoma, Bronchogenic | 1 | 2015 | 87 | 0.120 |
Why?
|
Fibrinogen | 1 | 2018 | 892 | 0.120 |
Why?
|
Decision Making | 2 | 2019 | 3961 | 0.120 |
Why?
|
Cryopreservation | 1 | 2020 | 731 | 0.120 |
Why?
|
Postoperative Period | 2 | 2016 | 1833 | 0.120 |
Why?
|
Lymphangiogenesis | 1 | 2015 | 172 | 0.110 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 783 | 0.110 |
Why?
|
Hepatitis B Antibodies | 1 | 2014 | 155 | 0.110 |
Why?
|
Lymphoproliferative Disorders | 1 | 2017 | 531 | 0.110 |
Why?
|
Pyridones | 1 | 2019 | 819 | 0.110 |
Why?
|
Opportunistic Infections | 1 | 2017 | 376 | 0.110 |
Why?
|
Cohort Studies | 10 | 2019 | 41797 | 0.110 |
Why?
|
Catheterization, Central Venous | 1 | 2019 | 530 | 0.110 |
Why?
|
Hepatitis C | 2 | 2019 | 1594 | 0.110 |
Why?
|
Hepatitis B Vaccines | 1 | 2014 | 177 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 4 | 2024 | 6537 | 0.110 |
Why?
|
Cross Infection | 1 | 2022 | 1425 | 0.110 |
Why?
|
Transplants | 1 | 2015 | 208 | 0.110 |
Why?
|
Telomerase | 2 | 2015 | 751 | 0.110 |
Why?
|
Maximum Tolerated Dose | 1 | 2015 | 890 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 1 | 2019 | 1855 | 0.100 |
Why?
|
Bronchi | 1 | 2016 | 847 | 0.100 |
Why?
|
Risk Assessment | 4 | 2018 | 24311 | 0.100 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13708 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2260 | 0.100 |
Why?
|
Herpesvirus 4, Human | 1 | 2017 | 1081 | 0.100 |
Why?
|
Hepacivirus | 1 | 2019 | 1342 | 0.100 |
Why?
|
Indoles | 1 | 2019 | 1834 | 0.090 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2017 | 616 | 0.090 |
Why?
|
Absorptiometry, Photon | 1 | 2017 | 1749 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2882 | 0.090 |
Why?
|
Mycobacterium | 1 | 2012 | 251 | 0.090 |
Why?
|
Lung Injury | 1 | 2015 | 435 | 0.090 |
Why?
|
Registries | 2 | 2024 | 8373 | 0.090 |
Why?
|
Cautery | 1 | 1990 | 73 | 0.090 |
Why?
|
Duodenal Diseases | 1 | 1990 | 101 | 0.090 |
Why?
|
Prospective Studies | 6 | 2023 | 54914 | 0.080 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 1226 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10784 | 0.080 |
Why?
|
Enzyme Inhibitors | 2 | 2018 | 3734 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2015 | 2932 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2279 | 0.080 |
Why?
|
Mood Disorders | 1 | 2016 | 1128 | 0.080 |
Why?
|
Young Adult | 10 | 2019 | 60045 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4285 | 0.080 |
Why?
|
Boston | 2 | 2019 | 9361 | 0.080 |
Why?
|
Mycoses | 1 | 2012 | 386 | 0.080 |
Why?
|
Family | 1 | 2020 | 3208 | 0.080 |
Why?
|
Cyclosporins | 1 | 1989 | 216 | 0.080 |
Why?
|
Hepatitis B | 1 | 2014 | 707 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10125 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2022 | 3805 | 0.080 |
Why?
|
Transplantation, Homologous | 2 | 2016 | 4834 | 0.080 |
Why?
|
Anticoagulants | 1 | 2023 | 4840 | 0.070 |
Why?
|
United States | 10 | 2024 | 73121 | 0.070 |
Why?
|
Pilot Projects | 2 | 2019 | 8730 | 0.070 |
Why?
|
Genetic Testing | 1 | 2021 | 3586 | 0.070 |
Why?
|
Meclofenamic Acid | 1 | 1986 | 23 | 0.070 |
Why?
|
Waiting Lists | 2 | 2024 | 778 | 0.070 |
Why?
|
Antifungal Agents | 1 | 2012 | 761 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4861 | 0.070 |
Why?
|
Double-Blind Method | 5 | 2022 | 12450 | 0.070 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3212 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2012 | 839 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11930 | 0.060 |
Why?
|
Respiratory Insufficiency | 1 | 2014 | 1244 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 20762 | 0.060 |
Why?
|
Administration, Inhalation | 2 | 2019 | 1170 | 0.060 |
Why?
|
Preoperative Care | 1 | 2014 | 2257 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8559 | 0.060 |
Why?
|
Bone Marrow | 1 | 2015 | 2929 | 0.060 |
Why?
|
Mass Screening | 1 | 2021 | 5455 | 0.060 |
Why?
|
Biopsy | 2 | 2015 | 6816 | 0.060 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2754 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9687 | 0.060 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2024 | 153 | 0.060 |
Why?
|
Liver | 2 | 2020 | 7575 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2015 | 3246 | 0.050 |
Why?
|
Massachusetts | 1 | 2016 | 8908 | 0.050 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1544 | 0.050 |
Why?
|
Autophagy | 2 | 2022 | 1349 | 0.050 |
Why?
|
Colitis | 2 | 1989 | 1244 | 0.050 |
Why?
|
Drug Contamination | 1 | 2022 | 152 | 0.050 |
Why?
|
Manometry | 1 | 2023 | 459 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7451 | 0.040 |
Why?
|
Disease Progression | 3 | 2023 | 13655 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5709 | 0.040 |
Why?
|
Endothelin-1 | 1 | 2001 | 302 | 0.040 |
Why?
|
Hepatitis C Antibodies | 1 | 2019 | 151 | 0.040 |
Why?
|
Electric Injuries | 1 | 1998 | 24 | 0.040 |
Why?
|
ROC Curve | 2 | 2016 | 3624 | 0.040 |
Why?
|
Aged, 80 and over | 7 | 2020 | 59680 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15965 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1103 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2024 | 3586 | 0.040 |
Why?
|
Carboxyhemoglobin | 1 | 2017 | 83 | 0.040 |
Why?
|
Adolescent | 5 | 2019 | 89168 | 0.040 |
Why?
|
North Carolina | 1 | 2018 | 327 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 501 | 0.040 |
Why?
|
Specialization | 1 | 2022 | 782 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2019 | 762 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 1246 | 0.030 |
Why?
|
Failure to Thrive | 1 | 1997 | 140 | 0.030 |
Why?
|
Mutation | 3 | 2015 | 30243 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6527 | 0.030 |
Why?
|
Water | 1 | 2022 | 1421 | 0.030 |
Why?
|
Hematologic Diseases | 1 | 2020 | 499 | 0.030 |
Why?
|
Prevalence | 3 | 2020 | 15880 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1760 | 0.030 |
Why?
|
Mucositis | 1 | 2017 | 108 | 0.030 |
Why?
|
Calcium | 1 | 1989 | 5793 | 0.030 |
Why?
|
RNA, Viral | 3 | 2019 | 2865 | 0.030 |
Why?
|
Safety | 1 | 2020 | 1159 | 0.030 |
Why?
|
Bronchodilator Agents | 1 | 2019 | 519 | 0.030 |
Why?
|
Benchmarking | 1 | 2022 | 1058 | 0.030 |
Why?
|
Research Report | 1 | 2018 | 369 | 0.030 |
Why?
|
Premenopause | 1 | 2019 | 1039 | 0.030 |
Why?
|
HIV Seropositivity | 2 | 1997 | 963 | 0.030 |
Why?
|
Growth | 1 | 1996 | 366 | 0.030 |
Why?
|
Acute Disease | 2 | 2015 | 7246 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2015 | 402 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2007 | 3629 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10601 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 527 | 0.030 |
Why?
|
Down-Regulation | 1 | 2021 | 2944 | 0.030 |
Why?
|
Immunization Schedule | 1 | 2014 | 227 | 0.030 |
Why?
|
Molecular Weight | 1 | 2015 | 2173 | 0.030 |
Why?
|
Genetic Markers | 1 | 2019 | 2604 | 0.030 |
Why?
|
Collagen | 1 | 2001 | 2646 | 0.030 |
Why?
|
Nervous System | 1 | 1996 | 547 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4545 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2022 | 1764 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14728 | 0.030 |
Why?
|
Gene Silencing | 1 | 2019 | 1503 | 0.030 |
Why?
|
Mycobacterium avium Complex | 1 | 2012 | 60 | 0.030 |
Why?
|
Echinocandins | 1 | 2012 | 53 | 0.030 |
Why?
|
Lipopeptides | 1 | 2012 | 71 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2018 | 964 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22293 | 0.020 |
Why?
|
Amphotericin B | 1 | 2012 | 143 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14766 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6135 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8753 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3207 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2017 | 867 | 0.020 |
Why?
|
Lymphatic Vessels | 1 | 2015 | 358 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1640 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2019 | 3794 | 0.020 |
Why?
|
Tuberous Sclerosis | 1 | 2019 | 1040 | 0.020 |
Why?
|
Prednisone | 1 | 2015 | 1568 | 0.020 |
Why?
|
Duodenoscopy | 1 | 1990 | 45 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1840 | 0.020 |
Why?
|
Observer Variation | 1 | 2017 | 2622 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1884 | 0.020 |
Why?
|
Aspergillosis | 1 | 2012 | 242 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4138 | 0.020 |
Why?
|
Diarrhea | 1 | 2017 | 1320 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3727 | 0.020 |
Why?
|
Postmenopause | 1 | 2019 | 2519 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2015 | 1036 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2011 | 417 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5801 | 0.020 |
Why?
|
Candidiasis | 1 | 2012 | 367 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3816 | 0.020 |
Why?
|
Glucose | 1 | 2001 | 4355 | 0.020 |
Why?
|
Observation | 1 | 2011 | 311 | 0.020 |
Why?
|
Schilling Test | 1 | 1988 | 3 | 0.020 |
Why?
|
Pancreatic Extracts | 1 | 1988 | 6 | 0.020 |
Why?
|
Pancreatin | 1 | 1988 | 8 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3697 | 0.020 |
Why?
|
Headache | 1 | 2017 | 1260 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6320 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2206 | 0.020 |
Why?
|
Viral Load | 1 | 1997 | 3399 | 0.020 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 1988 | 84 | 0.020 |
Why?
|
Triazoles | 1 | 2012 | 905 | 0.020 |
Why?
|
HIV Core Protein p24 | 2 | 1997 | 247 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3644 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6241 | 0.020 |
Why?
|
Lipase | 1 | 1988 | 321 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 1998 | 2544 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2430 | 0.020 |
Why?
|
Liver Diseases | 1 | 2014 | 1307 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2819 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2834 | 0.020 |
Why?
|
Angiography | 1 | 1990 | 1598 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9623 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9507 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1989 | 3073 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9376 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1990 | 1126 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18478 | 0.010 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2001 | 38 | 0.010 |
Why?
|
Sequence Tagged Sites | 1 | 2001 | 96 | 0.010 |
Why?
|
Transcription Factors | 1 | 2001 | 12174 | 0.010 |
Why?
|
Hemagglutinins | 1 | 2001 | 111 | 0.010 |
Why?
|
Collagen Type IV | 1 | 2001 | 125 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1998 | 6400 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1989 | 1397 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9642 | 0.010 |
Why?
|
Child | 2 | 2019 | 80863 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2001 | 19041 | 0.010 |
Why?
|
Rats | 2 | 2001 | 23839 | 0.010 |
Why?
|
Medication Adherence | 1 | 2011 | 2190 | 0.010 |
Why?
|
Patient Care Team | 1 | 2010 | 2526 | 0.010 |
Why?
|
Bethanechol | 1 | 1998 | 12 | 0.010 |
Why?
|
Parasympathomimetics | 1 | 1998 | 28 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15460 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2001 | 856 | 0.010 |
Why?
|
Peristalsis | 1 | 1998 | 60 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20231 | 0.010 |
Why?
|
Africa, Eastern | 1 | 1998 | 76 | 0.010 |
Why?
|
Muscarinic Agonists | 1 | 1998 | 91 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 9099 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22365 | 0.010 |
Why?
|
Isoenzymes | 1 | 2001 | 1685 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2001 | 1207 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2001 | 3594 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10358 | 0.010 |
Why?
|
Inflammatory Bowel Diseases | 1 | 1989 | 2444 | 0.010 |
Why?
|
Animals | 3 | 2015 | 169418 | 0.010 |
Why?
|
Head | 1 | 1996 | 927 | 0.010 |
Why?
|
Phosphorylation | 1 | 2001 | 8332 | 0.010 |
Why?
|
Body Height | 1 | 1996 | 1568 | 0.010 |
Why?
|
HIV Infections | 1 | 1996 | 17564 | 0.010 |
Why?
|
Aeromonas | 1 | 1989 | 17 | 0.010 |
Why?
|
Pancrelipase | 1 | 1988 | 7 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2001 | 4534 | 0.010 |
Why?
|
Gastric Juice | 1 | 1988 | 59 | 0.000 |
Why?
|
Birth Weight | 1 | 1997 | 2117 | 0.000 |
Why?
|
Pancreatic Function Tests | 1 | 1988 | 69 | 0.000 |
Why?
|
Mice | 1 | 2015 | 82045 | 0.000 |
Why?
|
Trypsin | 1 | 1988 | 494 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2001 | 12813 | 0.000 |
Why?
|
Body Weight | 1 | 1996 | 4630 | 0.000 |
Why?
|
Microspheres | 1 | 1988 | 789 | 0.000 |
Why?
|
Delayed-Action Preparations | 1 | 1988 | 969 | 0.000 |
Why?
|
Child Development | 1 | 1996 | 2328 | 0.000 |
Why?
|
Infant | 2 | 1997 | 36497 | 0.000 |
Why?
|
Saliva | 1 | 1988 | 854 | 0.000 |
Why?
|
Intestine, Small | 1 | 1988 | 1218 | 0.000 |
Why?
|
Cognition | 1 | 1996 | 7066 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1996 | 26395 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1989 | 13026 | 0.000 |
Why?
|